P2X7 receptor: An emerging target in central nervous system diseases

Trends in Pharmacological Sciences

Volumn 35, Issue 10, 2014, Pages 537-547

  Sperlágh, Beáta ^a   Illes, Peter ^b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

ATP; neurodegenerative diseases; P2X7 receptor; psychiatric disorders

Indexed keywords

INTERLEUKIN 6; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2X7 RECEPTOR ANTAGONIST; PURINERGIC RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; PURINERGIC P2X RECEPTOR ANTAGONIST;

AMINO TERMINAL SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; CARBOXY TERMINAL SEQUENCE; CELL TYPE; CENTRAL NERVOUS SYSTEM DISEASE; CYTOKINE RESPONSE; DEPRESSION; DISEASE ASSOCIATION; EPILEPTIC STATE; HUMAN; HUNTINGTON CHOREA; MOLECULAR BIOLOGY; MOOD DISORDER; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; SYNAPTIC TRANSMISSION; ANIMAL; MENTAL DISORDERS; METABOLISM; NEURODEGENERATIVE DISEASES;

ANIMALS; HUMANS; MENTAL DISORDERS; NEURODEGENERATIVE DISEASES; PURINERGIC P2X RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2X7;

EID: 84907899903     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2014.08.002     Document Type: Review

References (161)

1. B. Sperlágh P2X7 receptors in the nervous system Prog. Neurobiol. 78 2006 327 346
2. L.H. Jiang Insights into the molecular mechanisms underlying mammalian P2X7 receptor functions and contributions in diseases, revealed by structural modeling and single nucleotide polymorphisms Front. Pharmacol. 2013 10.3389/fphar.2013.00055
3. T. Kawate Crystal structure of the ATP-gated P2X(4) ion channel in the closed state Nature 460 2009 592 598
4. M. Hattori, and E. Gouaux Molecular mechanism of ATP binding and ion channel activation in P2X receptors Nature 485 2012 207 212
5. O. Stelmashenko Activation of trimeric P2X2 receptors by fewer than three ATP molecules Mol. Pharmacol. 82 2012 760 766
6. H.J. Bradley Residues 155 and 348 contribute to the determination of P2X7 receptor function via distinct mechanisms revealed by single-nucleotide polymorphisms J. Biol. Chem. 286 2011 8176 8187
7. S. Adriouch ADP-ribosylation at R125 gates the P2X7 ion channel by presenting a covalent ligand to its nucleotide binding site FASEB J. 22 2008 861 869
8. C. Guo Evidence for functional P2X4/P2X7 heteromeric receptors Mol. Pharmacol. 72 2007 1447 1456
9. L.S. Antonio P2X4 receptors interact with both P2X2 and P2X7 receptors in the form of homotrimers Br. J. Pharmacol. 163 2011 1069 1077
10. E. Adinolfi Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor FASEB J. 24 2010 3393 3404
11. M. Masin Expression, assembly and function of novel C-terminal truncated variants of the mouse P2X7 receptor: re-evaluation of P2X7 knockouts Br. J. Pharmacol. 165 2012 978 993
12. A. Nicke A functional P2X7 splice variant with an alternative transmembrane domain 1 escapes gene inactivation in P2X7 knock-out mice J. Biol. Chem. 284 2009 25813 25822
13. N. Schwarz Alternative splicing of the N-terminal cytosolic and transmembrane domains of P2X7 controls gating of the ion channel by ADP-ribosylation PLoS ONE 2012 10.1371/journal.pone.0041269
14. S.J. Fuller Genetics of the P2X7 receptor and human disease Purinergic Signal. 5 2009 257 262
15. S. Chaumont, and B.S. Khakh Patch-clamp coordinated spectroscopy shows P2X2 receptor permeability dynamics require cytosolic domain rearrangements but not Panx-1 channels Proc. Natl. Acad. Sci. U.S.A. 105 2008 12063 12068
16. S. Alloisio Evidence for two conductive pathways in P2X receptor: differences in modulation and selectivity J. Neurochem. 113 2010 796 806
17. C. Sun The second transmembrane domain of P2X7 contributes to dilated pore formation PLoS ONE 2013 10.1371/journal.pone.0061886
18. L.E. Browne P2X7 receptor channels allow direct permeation of nanometer-sized dyes J. Neurosci. 33 2013 3557 3566
19. A. Khadra Dual gating mechanism and function of P2X7 receptor channels Biophys. J. 104 2013 2612 2621
20. S.O. Suadicani ATP signaling is deficient in cultured Pannexin1-null mouse astrocytes Glia 60 2012 1106 1116
21. C. Marques-da-Silva Colchicine inhibits cationic dye uptake induced by ATP in P2X2 and P2X7 receptor-expressing cells: implications for its therapeutic action Br. J. Pharmacol. 163 2011 912 926
22. A.V. Alberto Is pannexin the pore associated with the P2X7 receptor? Naunyn Schmiedebergs Arch. Pharmacol. 386 2013 775 787
23. X.J. Xu Splice variants of the P2X7 receptor reveal differential agonist dependence and functional coupling with pannexin-1 J. Cell Sci. 125 2012 3776 3789
24. R.E. Sorge Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity Nat. Med. 18 2012 595 599
25. S.L. Able Receptor localization, native tissue binding and ex vivo occupancy for centrally penetrant P2X7 antagonists in the rat Br. J. Pharmacol. 162 2011 405 414
26. S.A. Deuchars Neuronal P2X7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems J. Neurosci. 21 2001 7143 7152
27. L. Atkinson Differential co-localisation of the P2X7 receptor subunit with vesicular glutamate transporters VGLUT1 and VGLUT2 in rat CNS Neuroscience 123 2004 761 768
28. T. Puthussery, and E.L. Fletcher Synaptic localization of P2X7 receptors in the rat retina J. Comp. Neurol. 472 2004 13 23
29. J.A. Sim Reanalysis of P2X7 receptor expression in rodent brain J. Neurosci. 24 2004 6307 6314
30. D.C. Henshall P2X receptors as targets for the treatment of status epilepticus Front. Cell. Neurosci. 2013 10.3389/fncel.2013.00237
31. D. Milius Up-regulation of P2X7 receptor-immunoreactivity by in vitro ischemia on the plasma membrane of cultured rat cortical neurons Neurosci. Lett. 446 2008 45 50
32. J.M. Krueger ATP and the purine type 2 X7 receptor affect sleep J. Appl. Physiol. (1985) 109 2010 1318 1327
33. P.A. Girotti Differential effects of undernourishment on the differentiation and maturation of rat enteric neurons Cell Tissue Res. 353 2013 367 380
34. D. Zhou Involvement of spinal microglial P2X7 receptor in generation of tolerance to morphine analgesia in rats J. Neurosci. 30 2010 8042 8047
35. A.N. Shrivastava Dynamic micro-organization of P2X7 receptors revealed by PALM based single particle tracking Front. Cell. Neurosci. 2013 10.3389/fncel.2013.00232
36. C. Csölle, and B. Sperlagh Peripheral origin of IL-1beta production in the rodent hippocampus under in vivo systemic bacterial lipopolysaccharide (LPS) challenge and its regulation by P2X(7) receptors J. Neuroimmunol. 219 2010 38 46
37. V.F. Labrousse Impaired interleukin-1beta and c-Fos expression in the hippocampus is associated with a spatial memory deficit in P2X(7) receptor-deficient mice PLoS ONE 2009 10.1371/journal.pone.0006006
38. M. Barbera-Cremades P2X7 receptor-stimulation causes fever via PGE2 and IL-1beta release FASEB J. 26 2012 2951 2962
39. Y.X. Chu Involvement of microglial P2X7 receptors and downstream signaling pathways in long-term potentiation of spinal nociceptive responses Brain Behav. Immun. 24 2010 1176 1189
40. A.M. Basso Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders Behav. Brain Res. 198 2009 83 90
41. C. Csölle The absence of P2X7 receptors (P2rx7) on non-haematopoietic cells leads to selective alteration in mood-related behaviour with dysregulated gene expression and stress reactivity in mice Int. J. Neuropsychopharmacol. 16 2013 213 233
42. G. Burnstock Cotransmission Curr. Opin. Pharmacol. 4 2004 47 52
43. B. Sperlágh Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus J. Neurochem. 81 2002 1196 1211
44. M. Marcoli P2X7 pre-synaptic receptors in adult rat cerebrocortical nerve terminals: a role in ATP-induced glutamate release J. Neurochem. 105 2008 2330 2342
45. W. Fu Activity and metabolism-related Ca2+ and mitochondrial dynamics in co-cultured human fetal cortical neurons and astrocytes Neuroscience 250 2013 520 535
46. C. Cervetto The P2X7 receptor as a route for non-exocytotic glutamate release: dependence on the carboxyl tail J. Neurochem. 124 2013 821 831
47. C. Cervetto Calmidazolium selectively inhibits exocytotic glutamate release evoked by P2X7 receptor activation Neurochem. Int. 60 2012 768 772
48. C. Csölle Neurochemical changes in the mouse hippocampus underlying the antidepressant effect of genetic deletion of P2X7 receptors PLoS ONE 2013 10.1371/journal.pone.0066547
49. + depolarization evokes ATP, adenosine and glutamate release from glia in rat hippocampus: a microelectrode biosensor study Br. J. Pharmacol. 167 2012 1003 1020
50. R. Khakpay Potentiation of the glutamatergic synaptic input to rat locus coeruleus neurons by P2X7 receptors Purinergic Signal. 6 2010 349 359
51. J.H. Cho P2X7 receptors enhance glutamate release in hippocampal hilar neurons Neuroreport 21 2010 865 870
52. C. Ficker Astrocyte-neuron interaction in the substantia gelatinosa of the spinal cord dorsal horn via P2X7 receptor-mediated release of glutamate and reactive oxygen species Glia 2014 10.1002/glia.22707
53. J. Xia Neurons respond directly to mechanical deformation with pannexin-mediated ATP release and autostimulation of P2X7 receptors J. Physiol. 590 2012 2285 2304
54. M.V. Bennett Connexin and pannexin hemichannels in inflammatory responses of glia and neurons Brain Res. 1487 2012 3 15
55. Y. Gutierrez-Martin P2X7 receptors trigger ATP exocytosis and modify secretory vesicle dynamics in neuroblastoma cells J. Biol. Chem. 286 2011 11370 11381
56. H.K. Tsao PKC-dependent ERK phosphorylation is essential for P2X7 receptor-mediated neuronal differentiation of neural progenitor cells Cell Death Dis. 2013 10.1038/cddis.2013.274
57. N. Messemer P2X7 receptors at adult neural progenitor cells of the mouse subventricular zone Neuropharmacology 73 2013 122 137
58. J. Zou ATP-P2X7 receptor signaling controls basal and TNFalpha-stimulated glial cell proliferation Glia 60 2012 661 673
59. A. del Puerto ATP-P2X7 receptor modulates axon initial segment composition and function in physiological conditions and brain injury Cereb Cortex 2014 10.1093/cercor/bhu035
60. F. Bianco A role for P2X7 in microglial proliferation J. Neurochem. 99 2006 745 758
61. M. Monif The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore J. Neurosci. 29 2009 3781 3791
62. B.J. Gu P2X(7) is a scavenger receptor for apoptotic cells in the absence of its ligand, extracellular ATP J. Immunol. 187 2011 2365 2375
63. M. Yamamoto P2X7 receptors regulate engulfing activity of non-stimulated resting astrocytes Biochem. Biophys. Res. Commun. 439 2013 90 95
64. J. Arbeloa P2X7 receptor blockade prevents ATP excitotoxicity in neurons and reduces brain damage after ischemia Neurobiol. Dis. 45 2012 954 961
65. A.B. Lämmer The P2 receptor antagonist PPADS supports recovery from experimental stroke in vivo PLoS ONE 2011 10.1371/journal.pone.0019983
66. S. Chen P2X7 receptor antagonism inhibits p38 mitogen-activated protein kinase activation and ameliorates neuronal apoptosis after subarachnoid hemorrhage in rats Crit. Care Med. 41 2013 e466 e474
67. D.E. Kimbler Activation of P2X7 promotes cerebral edema and neurological injury after traumatic brain injury in mice PLoS ONE 2012 10.1371/journal.pone.0041229
68. T.L. Roth Transcranial amelioration of inflammation and cell death after brain injury Nature 505 2014 223 228
69. W. Peng Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury Proc. Natl. Acad. Sci. U.S.A. 106 2009 12489 12493
70. N. Niyadurupola P2X7 receptor activation mediates retinal ganglion cell death in a human retina model of ischemic neurodegeneration Invest. Ophthalmol. Vis. Sci. 54 2013 2163 2170
71. A. Marcillo A reassessment of P2X7 receptor inhibition as a neuroprotective strategy in rat models of contusion injury Exp. Neurol. 233 2012 687 692
72. G. Stoll Combating innate inflammation: a new paradigm for acute treatment of stroke? Ann. N. Y. Acad. Sci. 1207 2010 149 154
73. K. Chu Inhibition of P2X7 receptor ameliorates transient global cerebral ischemia/reperfusion injury via modulating inflammatory responses in the rat hippocampus J. Neuroinflammation 2012 10.1186/1742-2094-9-69
74. Q. Yu Block of P2X7 receptors could partly reverse the delayed neuronal death in area CA1 of the hippocampus after transient global cerebral ischemia Purinergic Signal. 9 2013 663 675
75. M. Domercq P2X7 receptors mediate ischemic damage to oligodendrocytes Glia 58 2010 730 740
76. L.Y. Wang Downregulation of P2X7 receptor expression in rat oligodendrocyte precursor cells after hypoxia ischemia Glia 57 2009 307 319
77. J.E. Kim Blockade of P2X receptor prevents astroglial death in the dentate gyrus following pilocarpine-induced status epilepticus Neurol. Res. 31 2009 982 988
78. F. Dona Alteration of purinergic P2X4 and P2X7 receptor expression in rats with temporal-lobe epilepsy induced by pilocarpine Epilepsy Res. 83 2009 157 167
79. T. Engel Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice FASEB J. 26 2012 1616 1628
80. A. Jimenez-Pacheco Increased neocortical expression of the P2X7 receptor after status epilepticus and anticonvulsant effect of P2X7 receptor antagonist A-438079 Epilepsia 54 2013 1551 1561
81. J.E. Kim, and T.C. Kang The P2X7 receptor-pannexin-1 complex decreases muscarinic acetylcholine receptor-mediated seizure susceptibility in mice J. Clin. Invest. 121 2011 2037 2047
82. J.E. Kim P2X7 receptor activation ameliorates CA3 neuronal damage via a tumor necrosis factor-alpha-mediated pathway in the rat hippocampus following status epilepticus J. Neuroinflammation 2011 10.1186/1742-2094-8-62
83. J.E. Kim P2X7 receptor regulates leukocyte infiltrations in rat frontoparietal cortex following status epilepticus J. Neuroinflammation 2010 10.1186/1742-2094-7-65
84. J.E. Kim The effect of P2X7 receptor activation on nuclear factor-kappaB phosphorylation induced by status epilepticus in the rat hippocampus Hippocampus 23 2013 500 514
85. R.A. North, and M.F. Jarvis P2X receptors as drug targets Mol. Pharmacol. 83 2013 759 769
86. K. Itoh Central sensitization of nociceptive neurons in rat medullary dorsal horn involves purinergic P2X7 receptors Neuroscience 192 2011 721 731
87. R.D. Andó A comparative analysis of the activity of ligands acting at P2X and P2Y receptor subtypes in models of neuropathic, acute and inflammatory pain Br. J. Pharmacol. 159 2010 1106 1117
88. W.J. He Spinal P2X(7) receptor mediates microglia activation-induced neuropathic pain in the sciatic nerve injury rat model Behav. Brain Res. 226 2012 163 170
89. G. Ito P2X7 receptor in the trigeminal sensory nuclear complex contributes to tactile allodynia/hyperalgesia following trigeminal nerve injury Eur. J. Pain 17 2013 185 199
90. Z.X. Huang Involvement of RVM-expressed P2X7 receptor in bone cancer pain: mechanism of descending facilitation Pain 155 2014 783 791
91. F. Gölöncsér, and B. Sperlágh Effect of genetic deletion and pharmacological antagonism of P2X7 receptors in a mouse animal model of migraine J. Headache Pain 2014 10.1186/1129-2377-15-24
92. S. Amadio Purinergic signalling at the plasma membrane: a multipurpose and multidirectional mode to deal with amyotrophic lateral sclerosis and multiple sclerosis J. Neurochem. 116 2011 796 805
93. O. Oyanguren-Desez Gain-of-function of P2X7 receptor gene variants in multiple sclerosis Cell Calcium 50 2011 468 472
94. T. Grygorowicz Temporal expression of P2X7 purinergic receptor during the course of experimental autoimmune encephalomyelitis Neurochem. Int. 57 2010 823 829
95. C. Matute P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis J. Neurosci. 27 2007 9525 9533
96. A.J. Sharp P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis J. Neuroinflammation 2008 10.1186/1742-2094-5-33
97. -/- mice: evidence for loss of apoptotic activity in lymphocytes J. Immunol. 176 2006 3115 3126
98. S.E. Lutz Contribution of pannexin1 to experimental autoimmune encephalomyelitis PLoS ONE 2013 10.1371/journal.pone.0066657
99. C. Volonte ALS: focus on purinergic signalling Pharmacol. Ther. 132 2011 111 122
100. S. Apolloni Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis Hum. Mol. Genet. 22 2013 4102 4116
101. M. Gandelman Extracellular ATP and the P2X7 receptor in astrocyte-mediated motor neuron death: implications for amyotrophic lateral sclerosis J. Neuroinflammation 2010 10.1186/1742-2094-7-33
102. S. Apolloni The NADPH oxidase pathway is dysregulated by the P2X7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis J. Immunol. 190 2013 5187 5195
103. C. Delarasse The purinergic receptor P2X7 triggers alpha-secretase-dependent processing of the amyloid precursor protein J. Biol. Chem. 286 2011 2596 2606
104. J.M. Sanz Activation of microglia by amyloid {beta} requires P2X7 receptor expression J. Immunol. 182 2009 4378 4385
105. J.I. Diaz-Hernandez In vivo P2X7 inhibition reduces amyloid plaques in Alzheimer's disease through GSK3beta and secretases Neurobiol. Aging 33 2012 1816 1828
106. M.R. Carmo The P2X7 receptor antagonist Brilliant Blue G attenuates contralateral rotations in a rat model of Parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis Neuropharmacology 81 2014 142 152
107. D. Marcellino On the role of P2X(7) receptors in dopamine nerve cell degeneration in a rat model of Parkinson's disease: studies with the P2X(7) receptor antagonist A-438079 J. Neural Transm. 117 2010 681 687
108. Z. Hracskó Lack of neuroprotection in the absence of P2X7 receptors in toxin-induced animal models of Parkinson's disease Mol. Neurodegener. 2011 10.1186/1750-1326-6-28
109. M. Diaz-Hernandez Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration FASEB J. 23 2009 1893 1906
110. M. Iwata The inflammasome: pathways linking psychological stress, depression, and systemic illnesses Brain Behav. Immun. 31 2013 105 114
111. B. Sperlagh The role of purinergic signaling in depressive disorders Neuropsychopharmacol. Hung 14 2012 231 238
112. A. McQuillin Case-control studies show that a non-conservative amino-acid change from a glutamine to arginine in the P2RX7 purinergic receptor protein is associated with both bipolar- and unipolar-affective disorders Mol. Psychiatry 14 2009 614 620
113. P. Soronen P2RX7 gene is associated consistently with mood disorders and predicts clinical outcome in three clinical cohorts Am. J. Med. Genet. B: Neuropsychiatr. Genet. 156B 2011 435 447
114. S. Roger Single nucleotide polymorphisms that were identified in affective mood disorders affect ATP-activated P2X7 receptor functions J. Psychiatr. Res. 44 2010 347 355
115. M. Grigoroiu-Serbanescu Variation in P2RX7 candidate gene (rs2230912) is not associated with bipolar I disorder and unipolar major depression in four European samples Am. J. Med. Genet. B: Neuropsychiatr. Genet. 150B 2009 1017 1021
116. M. Viikki P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECT Neurosci. Lett. 493 2011 127 130
117. L. Backlund Cognitive manic symptoms associated with the P2RX7 gene in bipolar disorder Bipolar Disord. 13 2011 500 508
118. T. Hansen Variation in the purinergic P2RX(7) receptor gene and schizophrenia Schizophr. Res. 104 2008 146 152
119. F. Di Virgilio The therapeutic potential of modifying inflammasomes and NOD-like receptors Pharmacol. Rev. 65 2013 872 905
120. Y. Dowlati A meta-analysis of cytokines in major depression Biol. Psychiatry 67 2010 446 457
121. J.R. Lemos Modulation/physiology of calcium channel sub-types in neurosecretory terminals Cell Calcium 51 2012 284 292
122. R. Kongsui Chronic stress induces prolonged suppression of the P2X7 receptor within multiple regions of the hippocampus: a cumulative threshold spectra analysis Brain Behav. Immun. 2014 10.1016/j.bbi.2014.05.017
123. A.A. Boucher Resilience and reduced c-Fos expression in P2X7 receptor knockout mice exposed to repeated forced swim test Neuroscience 189 2011 170 177
124. T.C. Stock Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate J. Rheumatol. 39 2012 720 727
125. E.C. Keystone Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine Ann. Rheum. Dis. 71 2012 1630 1635
126. Z. Ali Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects Br. J. Clin. Pharmacol. 75 2013 197 207
127. R.J. Gum P2X receptor antagonists for pain management: examination of binding and physicochemical properties Purinergic Signal. 8 2012 41 56
128. A. Bhattacharya Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567 Br. J. Pharmacol. 170 2013 624 640
129. C. Hempel The phenothiazine-class antipsychotic drugs prochlorperazine and trifluoperazine are potent allosteric modulators of the human P2X7 receptor Neuropharmacology 75 2013 365 379
130. P. Marin-Garcia Synaptic terminals from mice midbrain exhibit functional P2X7 receptor Neuroscience 151 2008 361 373
131. A.E. Cuadra P2X7 receptors in neurohypophysial terminals: evidence for their role in arginine-vasopressin secretion J. Cell. Physiol. 229 2014 333 342
132. 3H]D-aspartate release from nerve terminals isolated from the rat caudal brainstem Neurochem. Int. 57 2010 623 628
133. A. Bhattacharya Potentiation of inhibitory synaptic transmission by extracellular ATP in rat suprachiasmatic nuclei J. Neurosci. 33 2013 8035 8044
134. M. Gandelman P2X7 receptor-induced death of motor neurons by a peroxynitrite/FAS-dependent pathway J. Neurochem. 126 2013 382 388
135. K. Nishida Mitochondrial dysfunction is involved in P2X7 receptor-mediated neuronal cell death J. Neurochem. 122 2012 1118 1128
136. J.F. Oliveira Rodent cortical astroglia express in situ functional P2X7 receptors sensing pathologically high ATP concentrations Cereb. Cortex 21 2011 806 820
137. W. Nörenberg Electrophysiological classification of P2X7 receptors in rat cultured neocortical astroglia Br. J. Pharmacol. 160 2010 1941 1952
138. L.M. Carrasquero Mechanisms of protein kinase D activation in response to P2Y(2) and P2X7 receptors in primary astrocytes Glia 58 2010 984 995
139. S. Hashioka Purinergic responses of calcium-dependent signaling pathways in cultured adult human astrocytes BMC Neurosci. 2014 10.1186/1471-2202-15-18
140. S. Habbas Purinergic signaling in the cerebellum: Bergmann glial cells express functional ionotropic P2X7 receptors Glia 59 2011 1800 1812
141. Y. Chen P2X7 receptors in satellite glial cells mediate high functional expression of P2X3 receptors in immature dorsal root ganglion neurons Mol. Pain 2012 10.1186/1744-8069-8-9
142. I. Arnoux Adaptive phenotype of microglial cells during the normal postnatal development of the somatosensory 'Barrel' cortex Glia 61 2013 1582 1594
143. S.A. Friedle The P2X7-Egr pathway regulates nucleotide-dependent inflammatory gene expression in microglia Glia 59 2011 1 13
144. D. Patel Connexin hemichannel and pannexin channel electrophysiology: how do they differ? FEBS Lett. 588 2014 1372 1378
145. J. Wang The food dye FD&C Blue No. 1 is a selective inhibitor of the ATP release channel Panx1 J. Gen. Physiol. 141 2013 649 656
146. A. Sikora Cutting edge: purinergic signaling regulates radical-mediated bacterial killing mechanisms in macrophages through a P2X7-independent mechanism J. Immunol. 163 1999 558 561
147. M. Solle Altered cytokine production in mice lacking P2X(7) receptors J. Biol. Chem. 276 2001 125 132
148. P. Garcia-Huerta The specificity protein factor Sp1 mediates transcriptional regulation of P2X7 receptors in the nervous system J. Biol. Chem. 287 2012 44628 44644
149. C.C. Chrovian P2X7 Antagonists as potential therapeutic agents for the treatment of CNS disorders Prog. Med. Chemistry 53 2014 65 100
150. P.J. Beswick Structure-activity relationships and in vivo activity of (1H-pyrazol-4-yl)acetamide antagonists of the P2X(7) receptor Bioorg. Med. Chem. Lett. 20 2010 4653 4656
151. L.J. Chambers Synthesis and structure-activity relationships of a series of (1H-pyrazol-4-yl)acetamide antagonists of the P2X7 receptor Bioorg. Med. Chem. Lett. 20 2010 3161 3164
152. X. Chen Discovery of 2-chloro-N-((4,4-difluoro-1-hydroxycyclohexyl)methyl)-5-(5-fluoropyrimidin-2-yl)benzamide as a potent and CNS penetrable P2X7 receptor antagonist Bioorg. Med. Chem. Lett. 20 2010 3107 3111
153. C. Subramanyam Discovery, synthesis and SAR of azinyl- and azolylbenzamides antagonists of the P2X(7) receptor Bioorg. Med. Chem. Lett. 21 2011 5475 5479
154. R.J. Gleave Synthesis and biological activity of a series of tetrasubstituted-imidazoles as P2X(7) antagonists Bioorg. Med. Chem. Lett. 20 2010 4951 4954
155. L. Abberley Identification of 2-oxo-N-(phenylmethyl)-4-imidazolidinecarboxamide antagonists of the P2X(7) receptor Bioorg. Med. Chem. Lett. 20 2010 6370 6374
156. S.M. Wilkinson The first CNS-active carborane: a novel P2X receptor antagonist with antidepressant activity ACS Chem. Neurosci. 55 2014 335 339
157. W. Nörenberg Clemastine potentiates the human P2X7 receptor by sensitizing it to lower ATP concentrations J. Biol. Chem. 286 2011 11067 11081
158. W. Nörenberg Positive allosteric modulation by ivermectin of human but not murine P2X7 receptors Br. J. Pharmacol. 167 2012 48 66
159. W. Fischer Natural compounds with P2X7 receptor-modulating properties Purinergic Signal. 2013 10.1007/s11302-013-9392-1
160. H.M. Costa-Junior C terminus of the P2X7 receptor: treasure hunting Purinergic Signal. 7 2011 7 19
161. G.E. Torres Hetero-oligomeric assembly of P2X receptor subunits. Specificities exist with regard to possible partners J. Biol. Chem. 274 1999 6653 6659